Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pang

Showing results (641-650 of 930) with videos related to

Pageof 93
Sort By:
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|June 27, 2019
[Analysis on the alterative trend of colorectal cancer mortality from 1999 to 2015 in Tianjin of China]D Z Wang, S Zhang, H Zhang, et al.
Lancet (London, England)|November 12, 2013
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trialEric Lawitz, Fred F Poordad, Phillip S Pang, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patientsHadas Dvory-Sobol, Kelly A Wong, Karin S Ku, et al.
Aging Cell|August 2, 2024
Retro-age: A unique epigenetic biomarker of aging captured by DNA methylation states of retroelementsLishomwa C Ndhlovu, Matthew L Bendall, Varun Dwaraka, et al.
Journal of Neurosurgery|February 5, 2004
Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridizationCarol Y K Tong, Angela B Y Hui, Xiao-Lu Yin, et al.
Cancer Gene Therapy|January 1, 1996
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vectorE M Toloza, K Hunt, S Swisher, et al.
Journal of Virology|October 1, 1990
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formationA J Cann, J A Zack, A S Go, et al.
Brain Tumor Pathology|January 9, 2014
Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five casesSiraj El Jamal, Shiyong Li, Renu Bajaj, et al.
Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimensDavid Wyles, Paul Pockros, Giuseppe Morelli, et al.
Gastroenterology|November 23, 2013
Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infectionEdward J Gane, Catherine A Stedman, Robert H Hyland, et al.
Pageof 93

Showing results (641-650 of 930) with videos related to

Sort By:
Pageof 93
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|June 27, 2019
[Analysis on the alterative trend of colorectal cancer mortality from 1999 to 2015 in Tianjin of China]D Z Wang, S Zhang, H Zhang, et al.
Lancet (London, England)|November 12, 2013
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trialEric Lawitz, Fred F Poordad, Phillip S Pang, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patientsHadas Dvory-Sobol, Kelly A Wong, Karin S Ku, et al.
Aging Cell|August 2, 2024
Retro-age: A unique epigenetic biomarker of aging captured by DNA methylation states of retroelementsLishomwa C Ndhlovu, Matthew L Bendall, Varun Dwaraka, et al.
Journal of Neurosurgery|February 5, 2004
Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridizationCarol Y K Tong, Angela B Y Hui, Xiao-Lu Yin, et al.
Cancer Gene Therapy|January 1, 1996
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vectorE M Toloza, K Hunt, S Swisher, et al.
Journal of Virology|October 1, 1990
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formationA J Cann, J A Zack, A S Go, et al.
Brain Tumor Pathology|January 9, 2014
Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five casesSiraj El Jamal, Shiyong Li, Renu Bajaj, et al.
Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimensDavid Wyles, Paul Pockros, Giuseppe Morelli, et al.
Gastroenterology|November 23, 2013
Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infectionEdward J Gane, Catherine A Stedman, Robert H Hyland, et al.
Pageof 93